Adjustable Continence Therapy Revenue and Competitors
Estimated Revenue & Valuation
- Adjustable Continence Therapy's estimated annual revenue is currently $8M per year.
- Adjustable Continence Therapy's estimated revenue per employee is $251,000
Employee Data
- Adjustable Continence Therapy has 32 Employees.
- Adjustable Continence Therapy grew their employee count by -22% last year.
Adjustable Continence Therapy's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director US Sales | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Engineering Manager | Reveal Email/Phone |
4 | Territory Sales Manager- New England | Reveal Email/Phone |
5 | Territory Sales Manager | Reveal Email/Phone |
6 | President, CEO and Co-Founder | Reveal Email/Phone |
7 | Quality and Operations Engineer | Reveal Email/Phone |
8 | Surgical Sales Specialist | Reveal Email/Phone |
9 | Territory Sales Manager | Reveal Email/Phone |
10 | Quality Engineer | Reveal Email/Phone |
Adjustable Continence Therapy Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $30.6M | 122 | 4% | N/A | N/A |
#2 | $18.6M | 74 | 35% | N/A | N/A |
#3 | $75.6M | 301 | 20% | N/A | N/A |
#4 | $12M | 48 | 4% | N/A | N/A |
#5 | $2.8M | 11 | 10% | N/A | N/A |
#6 | $3M | 12 | 0% | N/A | N/A |
#7 | $24.6M | 98 | 5% | N/A | N/A |
#8 | $11.5M | 46 | 21% | N/A | N/A |
#9 | $7.3M | 29 | 4% | N/A | N/A |
#10 | $13.8M | 55 | -10% | N/A | N/A |
What Is Adjustable Continence Therapy?
Uromedica, Inc. is a Minnesota-based medical device company that has developed long-term implantable balloon therapies for male and female stress urinary incontinence. Uromedica has safe and effective products that have been implanted in over 16,000 patients worldwide with excellent results. The balloons are implanted on either side of the bladder neck and do not require any patient manipulation. The implantation procedure takes approximately 30 minutes and the balloons are post-operatively adjustable through a subcutaneous port. The balloons may be easily removed during a safe and short office visit, if required, making Uromedica's devices truly minimally invasive. ProACT was FDA-approved for sale in the USA in November of 2015. ACT is not for sale in the USA. Uromedica will be commencing a clinical trial for ACT, the female application, in 2020.
keywords:N/A
N/A
Total Funding
32
Number of Employees
$8M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Plymouth
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.3M | 32 | -52% | N/A |
#2 | $8.4M | 32 | 3% | N/A |
#3 | $8.4M | 32 | -9% | N/A |
#4 | $2.6M | 32 | 0% | N/A |
#5 | $8.4M | 32 | -11% | N/A |